QuadVantage Technology

Transforming ACL Reconstruction Surgery
Overview
Raised: $298,208
Rolling Commitments ($USD)
04/30/2023
$1,514
2018
Healthcare & Pharmaceuticals
HealthTech
B2B
Low
High
Summary Profit and Loss Statement
Most Recent Year | Prior Year | |
---|---|---|
Revenue |
$0 |
$0 |
COGS |
$0 |
$0 |
Tax |
$670 |
$20 |
| ||
| ||
Net Income |
$-1,222,273 |
$-536,739 |
Summary Balance Sheet
Most Recent Year | Prior Year | |
---|---|---|
Cash |
$6,943 |
$3,829 |
Accounts Receivable |
$0 |
$0 |
Total Assets |
$25,166 |
$197,555 |
Short-Term Debt |
$1,796,792 |
$599,901 |
Long-Term Debt |
$204,617 |
$556,234 |
Total Liabilities |
$2,001,409 |
$1,156,135 |
Upgrade to gain access
-
$25 /month
billed annually - Free portfolio tracking, data-driven ratings, AI analysis and reports
- Plan Includes:
- Everything in Free, plus
- Company specific
KingsCrowd ratings and analyst reports
- Deal explorer and side-by-side comparison
- Startup exit and failure tracking
- Startup market filters and historical industry data
- Advanced company search ( with ratings)
- Get Edge Annual